• Indigenous Bloom Hemp (IBH) has appointed Chris Federowich to the board of directors
  • Indigenous Bloom Hemp (IBH) currently operates a large-scale industrial hemp farm in Southern Manitoba on approximately 200 acres of zoned farmland.
  • Indigenous Bloom Hemp (IBH) is unchanged today, trading at C$0.57 as of Aug 8, 2022, 4:36pm ET

Indigenous Bloom Hemp (IBH) has appointed Chris Federowich to the board of directors.

Mr. Federowich’s family are pioneers in the hemp industry and have been operating hemp farms in Manitoba for over 50 years. He is Vice Chair of the Parkland Industrial Hemp Growers, a new gen cooperative developing hemp varieties specifically designed for the Manitoba region.

Indigenous Bloom Hemp’s CEO, Mr. Mark Roseborough, commented:

“I believe that Mr. Federowich’s knowledge and experience in the hemp industry along with his dedication to seeing hemp become a commodity grown in Canada is another step towards strategically placing the Company in a position for success in the hemp industry.”

Indigenous Bloom Hemp (IBH) currently operates a large-scale industrial hemp farm in Southern Manitoba on approximately 200 acres of zoned farmland.

Indigenous Bloom Hemp (IBH) is unchanged today, trading at C$0.57 as of Aug 8, 2022, 4:36pm ET.


More From The Market Online
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.